A Controlled, Prospective, 1-Year Trial of Citalopram in the Treatment of Panic Disorder

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision

“…In a relapse prevention study over 52 weeks, it was superior to placebo and as effective as the TCA clomipramine (Lepola et al 1998). In a long-term study that included 24 weeks double-blind treatment and an open extension of another 26 weeks, citalopram was as effective as fluoxetine (Amore et al 1999b) (A).…”

“…In general, the frequency of adverse events is higher for TCAs than for newer antidepressants, such as the SSRIs (Amore et al 1999a;Bakish et al 1996;Bakker et al 1999;Bystritsky et al 1994;Lepola et al 1998;Wade et al 1997). Thus, the latter drugs should be tried first before TCAs are used.…”

13th National Congress of the South African Society of Psychiatrists, 20-23 September 2004

“…Patients with possible 22q11 DS were identified in a ongoing genetic study for schizophrenia, according to screening criteria proposed by Basset et al [2] This genetic study of schizophrenia at the University of Pretoria, Department of Psychiatry and the Human Neurogenetics Laboratory of The Rockefeller University has been ongoing since 1997.…”

“…The public health model's paradigm will be used to demonstrate specific opportunities and challenges in tobacco control in the mentally ill, namely (1). Cessation (pharmacotherapy and psychosocial interventions), (2). Denormalization, and (3).…”

“…1,2 There are divergent goals when considering trial duration. One goal is to ensure that patients have sufficient opportunity to remit by providing sufficient treatment exposure that may require a long trial duration.…”